Warfarin-A Natural Anticoagulant: A Review of Research Trends for Precision Medication
Background Warfarin is a widely prescribed anticoagulant in the clinic. It has a more
considerable individual variability, and many factors affect its variability. Mathematical …
considerable individual variability, and many factors affect its variability. Mathematical …
Double crosslinking decellularized bovine pericardium of dialdehyde chondroitin sulfate and zwitterionic copolymer for bioprosthetic heart valves with enhanced …
S Shi, M Hu, X Peng, C Cheng, S Feng… - Journal of Materials …, 2024 - pubs.rsc.org
Due to the increasing aging population and the advancements in transcatheter aortic valve
replacement (TAVR), the use of bioprosthetic heart valves (BHVs) in patients diagnosed with …
replacement (TAVR), the use of bioprosthetic heart valves (BHVs) in patients diagnosed with …
[HTML][HTML] Management and 1-Year Outcome in Elderly Patients with Hip Fracture Surgery Receiving Anticoagulation (Warfarin or DOAc) or P2Y12 Antiplatelet Agents
C Rostagno, G Rubbieri, M Zeppa, A Cartei… - Journal of Clinical …, 2023 - mdpi.com
(1) Background: Little prospective data exist regarding the perioperative management and
long-term prognosis of elderly patients receiving treatment with antithrombotic drugs and …
long-term prognosis of elderly patients receiving treatment with antithrombotic drugs and …
[HTML][HTML] Evaluation of a membrane filter and platelet-rich plasma (PRP) product obtained from a prototype PRP kit that works through a new method for separating …
S Jakfar, DS Ningsih, TC Lin, ZY Chen, FH Lin… - AIP Advances, 2024 - pubs.aip.org
The harvesting of platelet-rich plasma (PRP) from whole blood based on cell density is a
standard procedure that is currently applied to commercially available PRP kits. Leukocytes …
standard procedure that is currently applied to commercially available PRP kits. Leukocytes …
[HTML][HTML] Continuing Education Activity
A Agrawal, CC Kerndt, B Manna - europepmc.org
Apixaban Akanksha Agrawal; Connor C. Kerndt; Biagio Manna. Author Information Last Update:
February 22, 2024. Continuing Education Activity Apixaban is a novel oral anticoagulant …
February 22, 2024. Continuing Education Activity Apixaban is a novel oral anticoagulant …
Novel horizons in anticoagulation: the emerging role of factor XI inhibitors across different settings
Anticoagulants have long been fundamental in preventing and treating thromboembolic
disorders, with a recent shift of focus towards direct oral anticoagulants, thanks to their ease …
disorders, with a recent shift of focus towards direct oral anticoagulants, thanks to their ease …